Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
A Umeå University-led clinical trial is evaluating remote neuropsychological assessments for patients with various neurological conditions. …
-
FDA approval · 2026-03-31FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for valproic acid submitted by ANI Pharmaceuticals, Inc. The approval covers changes to the product …
-
FDA approval · 2026-03-31FDA Approved: VALPROIC ACID — Supplemental Application (Xttrium Laboratories Inc.)
FDA approved a supplemental application for VALPROIC ACID from Xttrium Laboratories Inc. The approval concerns changes to the generic produc…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation study of cenobamate in pediatric patients with partial-onset seizures. The st…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
A real-world evidence study is evaluating patient-reported outcomes for medical cannabis across pain, sleep, anxiety, depression, and epilep…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Korus: a Device to Prevent Sudden Unexpected Death in Epilepsy (SUDEP) [NA]
This is a ClinicalTrials.gov update indicating that the Korus device to prevent sudden unexpected death in epilepsy (SUDEP) is not yet recru…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Cenobamate in the Intensive Care Unit [EARLY_Phase 1]
An early-phase clinical trial update investigating cenobamate in an Intensive Care Unit setting for epilepsy and other neurological disorder…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy [Phase 1]
This Phase 1 UC Davis trial investigates imaging biomarkers of neuro-inflammation and their relationship to the risk of developing post-trau…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures [Phase 4]
Phase 4 clinical trial update on the pharmacokinetics, safety, and tolerability of ZONISADE in children aged 1 month to 17 years with partia…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of Direct Brain Recording and Stimulation for Memory Enhancement
A National Institute of Neurological Disorders and Stroke-supported clinical study is evaluating direct brain recording and electrical stimu…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy [NA]
This clinical trial update indicates that the study on Characterization of the Combined Alterations in Respiration and Arousal in Patients W…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MRgFUS for Childhood Epilepsy [NA]
A clinical trial evaluating magnetic resonance-guided focused ultrasound (MRgFUS) for epilepsy in children is listed as not yet recruiting. …
-
EMA approval · 2026-03-25EMA Authorised: Lyrica (pregabalin) — Upjohn EESV
The European Medicines Agency authorised pregabalin (brand Lyrica) for epilepsy, anxiety disorders, and neuralgia, with Upjohn EESV as the m…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK.
A terminated non-interventional UK study evaluated healthcare resource use and clinical outcomes in epilepsy patients treated with VNS Thera…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Magnetoencephalography in Children
ClinicalTrials.gov entry describes a pediatric magnetoencephalography study with recruiting status, investigating epilepsy and intracranial …
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Levetiracetam Three Times Daily in Epilepsy [Phase 3]
A Phase 3 clinical trial evaluating thrice-daily Levetiracetam for epilepsy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations [NA]
Clinical trial update describing acute stimulation and modulation of stereotyped high-frequency oscillations in epilepsy, with the study cur…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care [Phase 4]
A Phase 4 clinical trial is evaluating the use of a seizure rescue medication as part of a comprehensive epilepsy self-management package. R…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Acute Recording of Stereotyped High-Frequency Oscillations [NA]
Clinical trial update indicating an ongoing Mayo Clinic study on acute recording of stereotyped high-frequency oscillations in epilepsy; the…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Stimulation-Induced Changes in Fronto-Limbic Network [NA]
The update describes a study on stimulation-induced changes in the fronto-limbic network. Recruitment is ongoing at the University of Alabam…
-
FDA label_change · 2026-03-20FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited, resulting in labeling changes for the generi…
-
FDA approval · 2026-03-20FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, reflecting an update to the product's labeling un…
-
FDA approval · 2026-03-20FDA Approved: CARBAMAZEPINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for carbamazepine from Alembic Pharmaceuticals, enabling changes to the product's labeling.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Thalamus Seizure Detection With a Deep Brain Stimulator System [NA]
A Mayo Clinic-sponsored clinical trial is recruiting to evaluate a thalamus-targeted seizure-detection system using a deep brain stimulator …
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study of Soticlestat in Adults and Children With Rare Epilepsies [Phase 2]
Takeda reports termination of a Phase 2 study of Soticlestat in adults and children with rare epilepsies, with results posted.